Cited by 387Cancer-related gene regulationEpigenetics and DNA MethylationRNA modifications and cancer

The DOI matches its Crossref record; 166 of the 167 references it cites were found in a registry or an index.

Critical roles of non-histone protein lysine methylation in human tumorigenesis

Hamamoto, Ryuji, Saloura, Vassiliki, Nakamura, Yusuke·2015·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Several protein lysine methyltransferases and demethylases have been identified to have critical roles in histone modification. A large body of evidence has indicated that their dysregulation is involved in the development and progression of various diseases, including cancer, and these enzymes are now considered to be potential therapeutic targets. Although most studies have focused on histone methylation, many reports have revealed that these enzymes also regulate the methylation dynamics of non-histone proteins such as p53, RB1 and STAT3 (signal transducer and activator of transcription 3), which have important roles in human tumorigenesis. In this Review, we summarize the molecular functions of protein lysine methylation and its involvement in human cancer, with a particular focus on lysine methylation of non-histone proteins.

Integrity signals

Registry

Crossref · 10.1038/nrc3884

Cites

166 of 166 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Histone demethylation by a family of JmjC domain-containing proteins
Tsukada, Y.-I., Fang, J., Erdjument‐Bromage, H., Warren, M., Borchers, C. H., Tempst, P., & Zhang, Y. (2005) · Nature · doi:10.1038/nature04433 · Cited by 2,244
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature · doi:10.1038/nature11606 · Cited by 1,786
The HSP70 chaperone machinery: J proteins as drivers of functional specificity
Kampinga, H. H., & Craig, E. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2941 · Cited by 1,760

Flagged first, then by citations

Show all 167 references

1 of the 167 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Clarke, S. G. & Tamanoi, F. (eds) The Enzymes: Protein Methyltransferases Vol. 24 (Academic Press, 2006).

Sorted by citations

Control of protein stability by post-translational modifications
Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 896
The roles of DNA, RNA and histone methylation in ageing and cancer
Michalak, E. M., Burr, M. L., Bannister, A. J., & Dawson, M. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0143-1 · Cited by 549
Electrostatic Nucleic Acid Nanoassembly Enables Hybridization Chain Reaction in Living Cells for Ultrasensitive mRNA Imaging
Wu, Z., Liu, G.-Q., Yang, X., & Jiang, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01778 · Cited by 345
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 311
ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease
Lüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 264
Histone methylation and the DNA damage response
Gong, F., & Miller, K. M. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.09.003 · Cited by 265
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Wang, Y., Hu, J., Wu, S., Fleishman, J. S., Li, Y., Xu, Y.-S., Zou, W., Wang, J., Feng, Y., Chen, J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01720-0 · Cited by 225
Application of artificial intelligence technology in oncology: towards the establishment of precision medicine
Hamamoto, R., Suvarna, K., Yamada, M., Kobayashi, K., Shinkai, N., Miyake, M., Takahashi, M., Jinnai, S., Shimoyama, R., Sakai, A., et al. (2020) · Cancers · doi:10.3390/cancers12123532 · Cited by 207
Self-citation
Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α
Aguiló, F., Li, S., Balasubramaniyan, N., Sancho, A., Benko, S., Zhang, F., Vashisht, A. A., Rengasamy, M., Andino, B., Chen, C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.043 · Cited by 205
Recent Progress in Histone Demethylase Inhibitors
McAllister, T. E., England, K. S., Hopkinson, R. J., Brennan, P. E., Kawamura, A., & Schofield, C. J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01758 · Cited by 192
SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis
Wang, G., Long, J., Gao, Y., Zhang, W., Han, F., Xu, C. S., Sun, L., Yang, S.-C., Lan, J., Hou, Z., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0266-1 · Cited by 189
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis
Fang, L., Teng, H., Wang, Y., Liao, G., Weng, L., Li, Y., Wang, X., Jin, J., Jiao, C., Chen, L., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.06.002 · Cited by 185
Epigenetic modification of m6A regulator proteins in cancer
Wang, Y., Wang, Y., Patel, H. H., Chen, J., Wang, J., Chen, Z., & Wang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01810-1 · Cited by 178
KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis
Qian, X., Li, X., Shi, Z., Bai, X., Xia, Y., Zheng, Y., Xu, D., Chen, F., You, Y., Fang, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.019 · Cited by 169
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
Scheer, S., Ackloo, S. Z., Medina, T. D. S., Schapira, M., Li, F., Ward, J. A., Lewis, A. M., Northrop, J. P., Richardson, P. L., Kanıskan, H. Ü., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07905-4 · Cited by 131
Advances Toward Lsd1 Inhibitors for Cancer Therapy
Fu, X., Zhang, P., & Yu, B. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0068 · Cited by 133
Cell spheroids: the new frontiers in in vitro models for cancer drug validation
Chatzinikolaidou, Μ. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.024 · Cited by 134
The NSD Family of Protein Methyltransferases in Human Cancer
Vougiouklakis, T., Hamamoto, R., Nakamura, Y., & Saloura, V. (2015) · Epigenomics · doi:10.2217/epi.15.32 · Cited by 132
Self-citation
Nonhistone Lysine Methylation in the Regulation of Cancer PathwaysPreprint
Carlson, S. M., & Gozani, O. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026435 · Cited by 133
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease
Li, L. X., Fan, L. X., Zhou, J. X., Grantham, J. J., Calvet, J. P., Sage, J., & Li, X. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90921 · Cited by 125
Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine
Hamamoto, R., Komatsu, M., Takasawa, K., Asada, K., & Kaneko, S. (2019) · Biomolecules · doi:10.3390/biom10010062 · Cited by 128
Self-citation
PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer
Spangle, J. M., Dreijerink, K. M. A., Groner, A. C., Cheng, H.-L. M., Ohlson, C. E., Reyes, J. M., Lin, C. Y., Bradner, J. E., Zhao, J. J., Roberts, T. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.046 · Cited by 118
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Kim, D., Kim, K. I., & Baek, S. H. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00737-3 · Cited by 111
The Smyd family of methyltransferases: role in cardiac and skeletal muscle physiology and pathology
Tracy, C. M., Warren, J. S., Szulik, M. W., Wang, L., Garcia, J., Makaju, A., Russell, K. L., Miller, M. R., & Franklin, S. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.10.001 · Cited by 109
Beyond histones – the expanding roles of protein lysine methylation
Wu, Z., Connolly, J., & Biggar, K. K. (2017) · FEBS Journal · doi:10.1111/febs.14056 · Cited by 110
Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer
Batista, I. A., & Helguero, L. A. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0017-6 · Cited by 108
Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics
Olsen, J. B., Cao, X.-J., Han, B., Chen, L. H., Horvath, A., Richardson, T. I., Campbell, R. M., Garcia, B. A., & Nguyen, H. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053280 · Cited by 105
The emerging role of lysine methyltransferase SETD8 in human diseases
Milite, C., Feoli, A., Viviano, M., Rescigno, D., Cianciulli, A., Balzano, A. L., Mai, A., Castellano, S., & Sbardella, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0268-4 · Cited by 105
Going beyond Polycomb: EZH2 functions in prostate cancer
Park, S. H., Fong, K.-W., Mong, E. F., Martin, M. C., Schiltz, G. E., & Yu, J. (2021) · Oncogene · doi:10.1038/s41388-021-01982-4 · Cited by 113
SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency
Boehm, D., Jeng, M. Y., Camus, G., Gramatica, A., Schwarzer, R., Johnson, J. R., Hull, P. A., Montaño, M., Sakane, N., Pagans, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.011 · Cited by 100
Orchestration of H3K27 methylation: mechanisms and therapeutic implication
Pan, M., Hsu, M., Chen, L., & Hung, W. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2596-8 · Cited by 111
PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response
Kim, D., Nam, H. J., Lee, W., Yim, H. Y., Ahn, J.-Y., Park, S. W., Shin, H. R., Yu, R., Won, K., Bae, J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.002 · Cited by 102
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Nakakido, M., Deng, Z., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Neoplasia · doi:10.1016/j.neo.2015.03.002 · Cited by 99
Self-citation
Preserving genome integrity and function: the DNA damage response and histone modifications
Kim, J. J., Lee, S. Y., & Miller, K. M. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1620676 · Cited by 96
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Yi, X., Jiang, X., & Fang, Z.-M. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0711-4 · Cited by 92
Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression
Yuan, S., Natesan, R., Rivera, F. J. S., Li, J., Bhanu, N. V., Yamazoe, T., Lin, J., Merrell, A. J., Sela, Y., Thomas, S. K., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1299 · Cited by 92
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2
Eggert, E., Hillig, R. C., Koehr, S., Stöckigt, D., Weiske, J., Barak, N. N., Mowat, J., Brumby, T., Christ, C. D., ter Laak, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01890 · Cited by 93
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancerPreprint
Reynoird, N., Mazur, P. K., Stellfeld, T., Flores, N. M., Lofgren, S. M., Carlson, S. M., Brambilla, E., Hainaut, P., Kaznowska, E., Arrowsmith, C., et al. (2016) · Genes & Development · doi:10.1101/gad.275529.115 · Cited by 7
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Bertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 92
Lysine methylation of transcription factors in cancer
Han, D. H., Huang, M., Wang, T., Li, Z., Chen, Y., Liu, C., Lei, Z., & Chu, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1524-2 · Cited by 93
The posttranslational modifications of Hippo-YAP pathway in cancer
Yan, F., Qian, M., He, Q., Zhu, H., & Yang, B. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.07.006 · Cited by 86
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
Chasseloup, F., Bourdeau, I., Tabarin, A., Regazzo, D., Dumontet, C., Ladurelle, N., Tosca, L., Amazit, L., Proust, A., Scharfmann, R., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00236-9 · Cited by 86
Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
Hamamoto, R., & Nakamura, Y. (2016) · Cancer Science · doi:10.1111/cas.12884 · Cited by 86
Self-citation
PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis
Liu, A., Yu, C., Qiu, C., Wu, Q., Huang, C., Li, X., She, X., Wan, K., Liu, L., Li, M., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02674-x · Cited by 80
SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
Bottino, C., Peserico, A., Simone, C., & Caretti, G. (2020) · Cancers · doi:10.3390/cancers12010142 · Cited by 78
Advancing Covalent Ligand and Drug Discovery beyond Cysteine
Kim, G., Grams, R. J., & Hsu, K. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00001 · Cited by 84
Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells
Hino, S., Kohrogi, K., & Nakao, M. (2016) · Cancer Science · doi:10.1111/cas.13004 · Cited by 76
Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns
Portelli, M., & Baron, B. (2018) · Journal of Pregnancy · doi:10.1155/2018/2632637 · Cited by 84
SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis
Elkouris, M., Kontaki, H., Stavropoulos, A., Antonoglou, A., Nikolaou, K. C., Samiotaki, M. K., Szántai, E., Saviolaki, D., Brown, P. J., Sideras, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.051 · Cited by 75
Histone methylation and vascular biology
Wei, X., Yi, X., Zhu, X., & Jiang, D. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00826-4 · Cited by 78
NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein
Song, D., Lan, J., Chen, Y., Liu, A., Wu, Q., Zhao, C., Feng, Y., Wang, J., Luo, X., Cao, Z., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01747-z · Cited by 70
KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling
Yu, B., Su, J., Shi, Q., Liu, Q., Ma, J., Ru, G., Zhang, L., Zhang, J., Hu, X., & Tang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-29899-w · Cited by 67
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription
Takemoto, Y., Ito, A., Niwa, H., Okamura, M., Fujiwara, T., Hirano, T., Handa, N., Umehara, T., Sonoda, T., Ogawa, K., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01732 · Cited by 68
PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway
Vershinin, Z., Feldman, M., Chen, A., & Levy, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697292 · Cited by 63
Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
Oki, S., Sone, K., Oda, K., Hamamoto, R., Ikemura, M., Maeda, D., Takeuchi, M., Tanikawa, M., Mori‐Uchino, M., Nagasaka, K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16316 · Cited by 68
Self-citation
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
Song, C., Chen, T., He, L., Ma, N., Li, J., Rong, Y., Fang, Y., Liu, M., Xie, D., & Lou, W. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00435-1 · Cited by 65
Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach
Chen, C., Zhu, H. Y. H., Stauffer, F., Caravatti, G., Vollmer, S., Machauer, R., Holzer, P., Möbitz, H., Scheufler, C., Klumpp, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00167 · Cited by 64
Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export
Wang, K., Huang, W., Chen, R., Lin, P., Zhang, T., Ni, Y., Li, H., Wu, J., Sun, X., Geng, J., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.010 · Cited by 64
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure
Milite, C., Feoli, A., Horton, J. R., Rescigno, D., Cipriano, A., Pisapia, V., Viviano, M., Pepe, G., Amendola, G., Novellino, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b02008 · Cited by 65
Resolving DNA Damage: Epigenetic Regulation of DNA Repair
Karakaidos, P., Karagiannis, D., & Rampias, T. N. (2020) · Molecules · doi:10.3390/molecules25112496 · Cited by 64
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Zhang, Y., Rong, D., Li, B., & Wang, Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02055 · Cited by 63
SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
She, X., Wu, Q., Rao, Z., Song, D., Huang, C., Feng, S., Liu, A., Liu, L., Wan, K., Li, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202301871 · Cited by 62
Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and CRL4DCAF5 ubiquitin ligase
Leng, F., Yu, J., Zhang, C., Alejo, S., Hoang, N., Sun, H., Lu, F., & Zhang, H. (2018) · Nature Communications · doi:10.1038/s41467-018-04019-9 · Cited by 63
Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS
Liu, L., Zhang, X., Ding, H., Liu, X., Cao, D., Liu, Y., Liu, J., Lin, C., Zhang, N., Wang, G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01785-7 · Cited by 60
Regulation of hypoxia responses by flavin adenine dinucleotide‐dependent modulation of HIF‐1α protein stability
Yang, S., Park, Y. S., Cho, J. H., Moon, B., An, H., Lee, J. Y., Zhi, X., Wang, Y., Pocalyko, D. J., Lee, D. C., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201694408 · Cited by 63
The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3
Wang, C., Wang, Q., Xu, X., Xie, B., Zhao, Y. B., Li, N., & Cao, X. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170856 · Cited by 61
Discovery of the First-in-Class G9a/GLP Covalent Inhibitors
Park, K.-S., Xiong, Y., Yim, H., Vélez, J., Babault, N., Kumar, P., Liu, J., & Jin, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00652 · Cited by 36
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins
Buuh, Z. Y., Lyu, Z., & Wang, R. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01817 · Cited by 61
Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer
Zhao, W., Wang, M., Cai, M., Zhang, C.-H., Qiu, Y., Wang, X., Zhang, T., Zhou, H., Wang, J., Zhao, W., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110956 · Cited by 58
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer
Saloura, V., Vougiouklakis, T., Zewde, M. G., Deng, X., Kiyotani, K., Park, J.-H., Matsuo, Y., Lingen, M. W., Suzuki, T., Dohmae, N., et al. (2017) · Scientific Reports · doi:10.1038/srep40664 · Cited by 57
Self-citation
Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases
Niwa, H., & Umehara, T. (2017) · Epigenetics · doi:10.1080/15592294.2017.1290032 · Cited by 57
SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1
Yoshioka, Y., Suzuki, T., Matsuo, Y., Nakakido, M., Tsurita, G., Simone, C., Watanabe, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11898 · Cited by 58
Self-citation
SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells
Piao, L., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4760 · Cited by 58
Self-citation
PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents
Nakakido, M., Deng, Z., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5143 · Cited by 57
Self-citation
Unusual Suspects in the Twilight Zone Between the Hsp90 Interactome and Carcinogenesis
Vartholomaiou, E., Echeverría, P. C., & Picard, D. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.08.001 · Cited by 54
Lysine methylation signaling of non-histone proteins in the nucleus
Levy, D. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03142-0 · Cited by 56
DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines
Oktyabri, D., Ishimura, A., Tange, S., Terashima, M., & Suzuki, T. (2016) · Biochimie · doi:10.1016/j.biochi.2016.01.005 · Cited by 52
Biological function and regulation of histone and non-histone lysine methylation in response to DNA damage
Chen, Y., & Zhu, W. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw050 · Cited by 57
Methylation of UHRF1 by SET7 is essential for DNA double-strand break repair
Hahm, J. Y., Kim, J., Park, J. W., Kang, J., Kim, K., Kim, S.-R., Cho, H., & Seo, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky975 · Cited by 54
SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice
Ogawa, S., Fukuda, A., Matsumoto, Y., Hanyu, Y., Sono, M., Fukunaga, Y., Masuda, T., Araki, O., Nagao, M., Yoshikawa, T., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.047 · Cited by 56
A Genetically Encoded Allysine for the Synthesis of Proteins with Site‐Specific Lysine Dimethylation
Wang, Z. A., Zeng, Y., Kurra, Y., Wang, X., Tharp, J. M., Vatansever, E. C., Hsu, W. W., Dai, S. Y., Fang, X., & Liu, W. R. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201609452 · Cited by 51
Inhibition of CARM1‐Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer
Feng, S., Rao, Z., Zhang, J., She, X., Chen, Y., Wan, K., Li, H., Zhao, C., Feng, Y., Wang, G., et al. (2023) · Advanced Science · doi:10.1002/advs.202303484 · Cited by 51
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
Saloura, V., Vougiouklakis, T., Zewde, M. G., Kiyotani, K., Park, J.-H., Gao, G., Karrison, T. G., Lingen, M. W., Nakamura, Y., & Hamamoto, R. (2016) · Oncotarget · doi:10.18632/oncotarget.9897 · Cited by 48
Self-citation
Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling
Deng, X., Hamamoto, R., Vougiouklakis, T., Wang, R., Yoshioka, Y., Suzuki, T., Dohmae, N., Matsuo, Y., Park, J.-H., & Nakamura, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19646 · Cited by 50
Self-citation
Targeting post-translational modification of transcription factors as cancer therapy
Qian, M., Yan, F., Yuan, T., Yang, B., He, Q., & Zhu, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.005 · Cited by 47
Lysine methyltransferase inhibitors: where we are now
Feoli, A., Viviano, M., Cipriano, A., Milite, C., Castellano, S., & Sbardella, G. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00196e · Cited by 50
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
Zoma, M., Curti, L., Shinde, D. A., Albino, D., Mitra, A., Sgrignani, J., Mapelli, S. N., Sandrini, G., Civenni, G., Merulla, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24380-6 · Cited by 47
Small-molecule Inhibitors of Lysine Methyltransferases SMYD2 and SMYD3: Current Trends
Fabini, E., Manoni, E., Ferroni, C., Río, A. D., & Bartolini, M. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0380 · Cited by 46
Post‐translational control of transcription factors: methylation ranks highly
Carr, S. M., Roworth, A. P., Chan, C. S. C., & Thangue, N. B. L. (2015) · FEBS Journal · doi:10.1111/febs.13524 · Cited by 47
SET and MYND domain containing protein 3 in cancer.
Huang, L., & Xu, A. (2017) · PubMed Central · Cited by 45
Substrate Specificity of the HEMK2 Protein Glutamine Methyltransferase and Identification of Novel Substrates
Kušević, D., Kudithipudi, S., & Jeltsch, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.711952 · Cited by 44
Global Proteomics Analysis of Protein Lysine Methylation
Cao, X., & Garcia, B. A. (2016) · Current Protocols in Protein Science · doi:10.1002/cpps.16 · Cited by 44
Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase
Butler, K. V., Ma, A., Yu, W., Li, F., Tempel, W., Babault, N., Pittella-Silva, F., Shao, J., Wang, J., Luo, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01244 · Cited by 44
Unconventional protein post-translational modifications: the helmsmen in breast cancer
Liu, J., Wang, Q., Kang, Y., Xu, S., & Pang, D. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00756-z · Cited by 45
Recent Advances in Multidimensional Separation for Proteome Analysis
Yuan, H., Jiang, B., Zhao, B., Zhang, L., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04894 · Cited by 42
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., Dong, Y., Wang, M., Li, Y., Lu, S., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01381-6 · Cited by 44
SET1/MLL family of proteins: functions beyond histone methylation
Sugeedha, J., Gautam, J., & Tyagi, S. (2020) · Epigenetics · doi:10.1080/15592294.2020.1809873 · Cited by 46
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
Lee, J., Kim, K., Ryu, T. Y., Jung, C., Lee, M., Lim, J. H., Park, K., Kim, D., Son, M., Hamamoto, R., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13050 · Cited by 42
Self-citation
Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors
Ji, Y.-Y., Lin, S., Wang, Y., Su, M., Zhang, W., Gunosewoyo, H., Yang, F., Li, J. X., Tang, J., Zhou, Y., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.073 · Cited by 42
Effects of SMYD 2‐mediated EML 4‐ ALK methylation on the signaling pathway and growth in non‐small‐cell lung cancer cells
Wang, R., Deng, X., Yoshioka, Y., Vougiouklakis, T., Park, J., Suzuki, T., Dohmae, N., Ueda, K., Hamamoto, R., & Nakamura, Y. (2017) · Cancer Science · doi:10.1111/cas.13245 · Cited by 40
Self-citation

Authors: Hamamoto, R., Saloura, V., & Nakamura, Y.
Affiliations: University of Chicago (US)
Corresponding author: Hamamoto, Ryuji
ORCID: Hamamoto, Ryuji
Saloura, Vassiliki
Nakamura, Yusuke
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2015-01-23
Volume: 15
Issue: 2
Pages: 110-124
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3884
OpenAlex: W2036357556
Cited by: 376
References: 167
Citations by year: 2026: 14 · 2025: 20 · 2024: 27 · 2023: 29 · 2022: 36 · 2021: 30 · 2020: 39 · 2019: 38 · 2018: 33 · 2017: 38 · 2016: 49 · 2015: 22
FWCI: 4.69
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
Keywords: carcinogenesis, p53, RB1, STAT3, lysine methyltransferase, demethylases, cancer therapy targets, histone modifications
MeSH terms: Cell Transformation, Neoplastic, Chromosomal Proteins, Non-Histone, Humans, Lysine, Methylation, Histone-Lysine N-Methyltransferase, Tumor Suppressor Protein p53, Retinoblastoma Protein, STAT3 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Critical roles of non-histone protein lysine methylation in human tumorigenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks